18551314. USE OF OXYMETHYL-MODIFIED DERIVATIVE OF QUERCETIN IN PREPARATION OF DRUG FOR INHIBITING TUMOR CELL PROLIFERATION simplified abstract (ZHEJIANG UNIVERSITY)

From WikiPatents
Jump to navigation Jump to search

USE OF OXYMETHYL-MODIFIED DERIVATIVE OF QUERCETIN IN PREPARATION OF DRUG FOR INHIBITING TUMOR CELL PROLIFERATION

Organization Name

ZHEJIANG UNIVERSITY

Inventor(s)

Chongde Sun of Hangzhou, Zhejiang (CN)

Yue Wang of Hangzhou, Zhejiang (CN)

Yunyi Chen of Hangzhou, Zhejiang (CN)

Jinping Cao of Hangzhou, Zhejiang (CN)

Xian Li of Hangzhou, Zhejiang (CN)

USE OF OXYMETHYL-MODIFIED DERIVATIVE OF QUERCETIN IN PREPARATION OF DRUG FOR INHIBITING TUMOR CELL PROLIFERATION - A simplified explanation of the abstract

This abstract first appeared for US patent application 18551314 titled 'USE OF OXYMETHYL-MODIFIED DERIVATIVE OF QUERCETIN IN PREPARATION OF DRUG FOR INHIBITING TUMOR CELL PROLIFERATION

Simplified Explanation

The present disclosure relates to the use of an oxymethyl-modified derivative of quercetin in the preparation of a drug for inhibiting tumor cell proliferation. The derivative may inhibit tumor cell proliferation, inhibit proliferation of a transplanted tumor in vivo, inhibit tumor cell metastasis, and induce tumor cell apoptosis.

  • Oxymethyl-modified derivative of quercetin used in drug preparation
  • Inhibits tumor cell proliferation
  • Inhibits proliferation of transplanted tumors in vivo
  • Inhibits tumor cell metastasis
  • Induces tumor cell apoptosis

Potential Applications

The technology can be applied in the development of anti-cancer drugs targeting tumor cell proliferation and metastasis.

Problems Solved

This technology addresses the need for effective drugs that can inhibit tumor cell proliferation, metastasis, and induce apoptosis in cancer cells.

Benefits

The use of oxymethyl-modified derivative of quercetin offers a potential treatment option for cancer patients by targeting tumor cells and inhibiting their growth and spread.

Potential Commercial Applications

The technology has potential applications in the pharmaceutical industry for the development of novel anti-cancer drugs.

Possible Prior Art

Previous studies have explored the use of quercetin derivatives in cancer treatment, but the specific oxymethyl-modified derivative described in this disclosure appears to be a novel approach.

Unanswered Questions

How does the oxymethyl-modified derivative of quercetin compare to other anti-cancer drugs in terms of efficacy and side effects?

The article does not provide a comparison with other anti-cancer drugs, so it is unclear how the oxymethyl-modified derivative of quercetin stacks up against existing treatments in terms of effectiveness and potential side effects.

What are the potential challenges in translating this technology from preclinical studies to clinical trials and eventual commercialization?

The article does not address the potential hurdles or challenges that may arise in the process of moving this technology from the laboratory to clinical settings and commercial production.


Original Abstract Submitted

The present disclosure relates to use of an oxymethyl-modified derivative of quercetin in preparation of a drug for inhibiting tumor cell proliferation, and belongs to the technical field of drug preparation. The present disclosure provides use of an oxymethyl-modified derivative of quercetin in preparation of a drug for inhibiting tumor cell proliferation. The oxymethyl-modified derivative of quercetin may inhibit tumor cell proliferation, inhibit proliferation of a transplanted tumor in vivo, inhibit tumor cell metastasis, and induce tumor cell apoptosis.